Mabpharm Limited (2181.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.85B |
| Enterprise Value | 2.07B |
| P/E Ratio | 20.44 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 2.26 |
| Price/Book Ratio | 8.92 |
| Enterprise/Revenue | 2.54 |
| Enterprise/EBITDA | 20.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.05 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.48 |
Income Statement
| Revenue | 629.37M |
| Revenue/Share | 0.19 |
| Gross Profit | 521.55M |
| EBITDA | 62.91M |
| Net Income | 55.65M |
| Diluted EPS | 0.01 |
Balance Sheet
| Total Cash | 93.31M |
| Total Cash/Share | 0.02 |
| Total Debt | 307.88M |
| Total Debt/Equity | 1.59 |
| Current Ratio | 0.83 |
| Book Value Per Share | 0.05 |
Price History
| 52-Week Change | -19.67 |
| 52-Week High | 0.81 |
| 52-Week Low | 0.31 |
| Moving Average 50 Days | 0.43 |
| Moving Average 200 Days | 0.46 |
Statistics
| Average Volume | 39,218 |
| Shares Outstanding | 4.12B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
